Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix-Reference-Cited by-同舟云学术

Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix

Published:2005-06 Issue:3 Volume:97 Page:840-844
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Jenkins Alfred D.,Ramondetta Lois M.,Sun Charlotte,Johnston Taren,Wolf Judith K.,Bodurka Diane C.,Brown Jubilee,Atkinson Edward N.,Levenback Charles

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference32 articles.

1. SEER cancer statistics review. [online, 2003]. [cited, 2001] Available from: URL: http://www.Seer.cancer.gov.

2. The epidemiology of cervical cancer;Franco;Cancer,2003

3. Report of the Task Force of the Department of Health and Welfare of Canada. Cervical cancer screening programs. The Walton Report;Report;Can. Med. Assoc. J.,1982

4. Chemotherapy of carcinoma of the cervix;Malkasian;Gynecol. Oncol.,1976

5. Single agent chemotherapy in carcinoma of the cervix;Thigpen,1987

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Capecitabine in treating patients with advanced, persistent, or recurrent cervical cancer: an active and safe option?;Expert Opinion on Drug Safety;2021-02-15

2. Capecitabine in patients with platinum-pretreated advanced or recurrent cervical carcinoma: a retrospective study;International Journal of Gynecologic Cancer;2019-01-13

3. A pilot feasibility study for cisplatin plus S-1 for the treatment for advanced or recurrent cervical cancer;Cancer Chemotherapy and Pharmacology;2013-04-05

4. Management of recurrent cervical cancer: A review of the literature;Surgical Oncology;2012-06

5. Phase II study of S-1, an oral fluoropyrimidine, in patients with advanced or recurrent cervical cancer;Annals of Oncology;2011-06